We present several methods to improve the resolution of human brain mapping by combining information obtained from surface electroencephalography (EEG) and functional magnetic resonance imaging (fMRI) of the same participants performing the same task in separate imaging sessions. As an initial step in our methods we used independent component analysis (ICA) to obtain task-related sources for both EEG and fMRI. We then used that information in an integrated cost function that attempts to match both data sources and trades goodness of fit in one regime for another. We compared the performance and drawbacks of each method in localizing sources for a dual visual evoked response experiment, and we contrasted the results of adding fMRI information to simple EEG-only inversion methods. We found that adding fMRI information in a variety of ways gives superior results to classical minimum norm source estimation. Our findings lead us to favor a method which attempts to match EEG scalp dynamics along with voxel power obtained from ICA-processed blood oxygenation level dependent (BOLD) data; this method of joint inversion enables us to treat the two data sources as symmetrically as possible.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neuroimage.2009.10.011DOI Listing

Publication Analysis

Top Keywords

human brain
8
brain mapping
8
joint inversion
8
attempts match
8
data sources
8
adding fmri
8
improving human
4
mapping joint
4
inversion brain
4
brain electrodynamics
4

Similar Publications

Epilepsy Stands Nearby: A Pilot CT Perfusion Study on Post-Stroke Non-Convulsive Status Epilepticus.

Eur J Neurol

February 2025

IRCCS Istituto delle Scienze Neurologiche di Bologna, Department of Neurology and Stroke Center, Maggiore Hospital, Bologna, Italy.

Background: To investigate the relevance of hyperperfusion on computerised perfusion imaging (CTP) in the emergency setting in people with non-convulsive status epilepticus (NCSE) and previous stroke, to derive relevant aspects on the epileptogenic focus and the network recruited for NCSE propagation.

Methods: We enrolled consecutive adult patients with acute-onset NCSE and a previous stroke at a single institution undergoing CTP and EEG during symptoms. All patients underwent standard imaging including CT, CTP, CT angiograms and standard EEG within 30 min from hospital arrival.

View Article and Find Full Text PDF

Background: Biallelic pathogenic variants in the FUCA1 gene are associated with fucosidosis. This report describes a 4-year-old boy presenting with psychomotor regression, spasticity, and dystonic postures.

Methods And Results: Trio-based whole exome sequencing revealed two previously unreported loss-of-function variants in the FUCA1 gene.

View Article and Find Full Text PDF

Background: Degeneration of the basal forebrain cholinergic system is a hallmark feature shared by Alzheimer's disease (AD) and Lewy body disease (LBD) whereas hippocampus atrophy is more specifically related to AD. We aimed to investigate the relationship between basal forebrain and hippocampus atrophy, cognitive decline, and neuropathology in a large autopsy sample.

Methods: Data were obtained from the National Alzheimer's Coordinating Center (NACC).

View Article and Find Full Text PDF

In this work, we introduce spatial and chemical saturation options for artefact reduction in magnetic resonance fingerprinting (MRF) and assess their impact on T and T mapping accuracy. An existing radial MRF pulse sequence was modified to enable spatial and chemical saturation. Phantom experiments were performed to demonstrate flow artefact reduction and evaluate the accuracy of the T and T maps.

View Article and Find Full Text PDF

Second-generation anti-amyloid monoclonal antibodies for Alzheimer's disease: current landscape and future perspectives.

Transl Neurodegener

January 2025

Department of Biochemistry, College of Medicine, Konyang University, 158, Gwanjeodong-Ro Seo-Gu, Daejeon, 35365, Republic of Korea.

Alzheimer's disease (AD) is the most common type of dementia. Monoclonal antibodies (MABs) serve as a promising therapeutic approach for AD by selectively targeting key pathogenic factors, such as amyloid-β (Aβ) peptide, tau protein, and neuroinflammation. Specifically, based on their efficacy in removing Aβ plaques from the brains of patients with AD, the U.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!